Home

Foresite Capital Management V, LLC

CIK 1792206 · last filed 2023-04-06

Foresite Capital Management V, LLC is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider bought $3.5M of PRDS on Apr 6, 2023. Across all open-market trades the lifetime net is +$5.1M, making them a net buyer over the disclosed history. The firm reports its address in West Hollywood, CA. 34 SEC filings were submitted jointly with Foresite Capital Fund V, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

5

Lifetime Open-Market Net

$5.11M

Filer Profile

Reported Address
9200 SUNSET BOULEVARD
SUITE PH1
WEST HOLLYWOOD, CA 90069
Phone
(415) 877-4887
State of Incorporation
DE
Related Filers
Foresite Capital Fund V, L.P. — 34 joint filings, latest 2026-08-10
Foresite Capital Opportunity Fund V, L.P. — 26 joint filings, latest 2026-08-10
Foresite Capital Opportunity Management V, LLC — 26 joint filings, latest 2026-08-10
James B. Tananbaum — 14 joint filings, latest 2023-08-31
Foresite Capital Fund IV, L.P. — 10 joint filings, latest 2026-02-06
Foresite Capital Fund VI LP — 9 joint filings, latest 2026-08-10
Foresite Capital Management VI LLC — 9 joint filings, latest 2026-08-10
Foresite Labs Fund I, L.P. — 7 joint filings, latest 2026-04-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PARDES BIOSCIENCES, INC. (PRDS) Delisted 10%+ Owner 13,583,762 $2.16 $29.34M $5.11M 4 2023-04-06
Kinnate Biopharma Inc. (KNTE) Delisted 10%+ Owner 9,671,643 $2.65 $25.63M $0 1 2020-12-09

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-04-06 PARDES BIOSCIENCES, INC. (PRDS) Delisted Buy (P) +2,321,856 $3.48M EDGAR
2022-12-05 PARDES BIOSCIENCES, INC. (PRDS) Delisted Buy (P) +1,912,260 $1.63M EDGAR
2022-06-10 PARDES BIOSCIENCES, INC. (PRDS) Delisted Grant (A) — $0 EDGAR
2021-12-28 PARDES BIOSCIENCES, INC. (PRDS) Delisted Mixed +68,164,110 $50.00M EDGAR
2020-12-09 Kinnate Biopharma Inc. (KNTE) Delisted Conv (C) +59,029,866 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.